Stock Market & Financial Investment News

News Breaks January 24, 2012 06:03 EDT ACHN theflyonthewall.com: Achillion recent pullback a buying opportunity, says Piper Jaffray Piper Jaffray views the recent pullback in shares of Achillion as providing an attractive entry point into the name. The firm continues to believe Achillion is a likely takeover target in the Hepatitis C virus space and reiterates an Overweight rating on the stock with a $17 price target. :theflyonthewall.com News For ACHN From The Last 14 Days Check below for free stories on ACHN the last two weeks. There are 7 items on the Fly with pertinent information. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2012 07:01 EDT ACHN theflyonthewall.com: Achillion announces additional proof-of-concept data with ACH-2684 for HepC Subscribe for More Information :theflyonthewall.com May 15, 2012 09:00 EDT ACHN theflyonthewall.com: Achillion rises 7.4% Subscribe for More Information :theflyonthewall.com 08:59 EDT ACHN theflyonthewall.com: Achillion gaps up after ACH-3102 fast-tracked, resistance at $7.63, $8.09 Subscribe for More Information :theflyonthewall.com 07:16 EDT ACHN theflyonthewall.com: Achillion's ACH-3102 receives fast track designation From FDA Subscribe for More Information :theflyonthewall.com May 10, 2012 08:42 EDT ACHN theflyonthewall.com: Achillion shares at good entry point, says RW Baird Subscribe for More Information :theflyonthewall.com May 9, 2012 16:18 EDT ACHN theflyonthewall.com: Achillion reports Q1 EPS (13c), consensus (15c) Subscribe for More Information :theflyonthewall.com 07:15 EDT ACHN theflyonthewall.com: Achillion advances 2nd generation pan-genotypic NS5A inhibitor into clinicals Subscribe for More Information :theflyonthewall.com